Cancer Stem Cells (CSCs) in Drug Resistance and their Therapeutic Implications in Cancer Treatment

Citations

WEB OF SCIENCE

836
Citations

SCOPUS

925

초록

Cancer stem cells (CSCs), also known as tumor-initiating cells (TICs), are suggested to be responsible for drug resistance and cancer relapse due in part to their ability to self-renew themselves and differentiate into heterogeneous lineages of cancer cells. Thus, it is important to understand the characteristics and mechanisms by which CSCs display resistance to therapeutic agents. In this review, we highlight the key features and mechanisms that regulate CSC function in drug resistance as well as recent breakthroughs of therapeutic approaches for targeting CSCs. This promises new insights of CSCs in drug resistance and provides better therapeutic rationales to accompany novel anticancer therapeutics.

키워드

cancer stem cellsEPITHELIAL-MESENCHYMAL TRANSITIONTUMOR-INITIATING CELLSACUTE MYELOID-LEUKEMIAALDEHYDE DEHYDROGENASE-ACTIVITYHEDGEHOG-SIGNALING PATHWAYSELF-RENEWALPROSTATE-CANCERENDOTHELIAL-CELLSSIDE POPULATIONSOLID TUMORS
제목
Cancer Stem Cells (CSCs) in Drug Resistance and their Therapeutic Implications in Cancer Treatment
저자
Lan Thi Hanh PhiSari, Ita NovitaYang, Ying-GuiLee, Sang-HyunJun, NayoungKim, Kwang SeockLee, Yun KyungKwon, Hyog Young
DOI
10.1155/2018/5416923
발행일
2018
유형
Review
저널명
Stem Cells International
2018